Investigators observed that previous infection with SARS-CoV-2, but not the standard two-dose regimen of vaccination, provided protection against symptomatic COVID-19 in kidney transplant recipients.
[Science Translational Medicine]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
171396
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
